Amy S. Paller, MD, principal investigator of the phase 3 LIBERTY AD PEDS trial, discusses the add-on biologic's benefit for young patients and potential as a pediatrc allergic therapy.

Dr. Kaneko, a cardiac surgeon at Brigham and Women's Hospital, breaks down a trio of studies he was associated with from ACC.20, including a look into PLO FLOW TAVR, the July Effect, and alternative access TAVR.

The ORION-11 principal investigator highlights new LDL-C reduction findings and teases future research for the siRNA-targeting drug.

Ralph Sacco, MD, chairman of the Department of Neurology and Olemberg Family Chair in Neurological Disorders Miller Professor of Neurology at the University of Miami, discusses advances in stroke care and his biggest takeaways from ISC 2020. 

Anna Lembke, MD, discusses the history of the opioid epidemic. 

A discussion on the state of rare disease with Sika Dunyoh, Director of Education Programs at the National Organization of Rare Disorders, for Rare Disease Day 2020. 

A discussion on prescribing bempedoic acid in a real-world setting with steering committee chair Christie Ballantyne, MD, chief of Cardiology at Baylor College of Medicine. 

David Lee, MD, discusses barbershop initiatives, their effectiveness, applicability in a real-world setting, and how they impact the health of a community as a whole.